Biotechnology Research Report

  North America Sports Nutrition Industry Overview The North America sports nutrition market size was valued at USD 12.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2028. Increasing awareness about the health benefits of consuming sports nutrition products among bodybuilders and athletes is driving the market growth. Moreover, the increasing number of gym-goers and active lifestyle consumers’ adoption of sports nutrition products is further supporting market growth potential. Demand for sports nutrition products is growing rapidly from core users and active lifestyle consumers in North America. Light users consumed sports nutrition products specifically targeting muscle support, energy, weight management, and healthy snacking. Core users or heavy users are focused on sports supplements required for muscle building, strength performance, endurance, and recovery. Consumers involved in strength training are major consumers o...

  Viral Vector Production (Research-use) Industry Overview The global viral vector production (research-use) market size was valued at USD 993.0 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 18.8% from 2021 to 2028. Rapid and extensive R&D in the advanced therapy arena has resulted in the growing employment of viral vectors in research settings. Also, the ongoing COVID-19 pandemic has encouraged investment in this space for vaccine development against SARS-CoV-2, thereby driving the market for viral vector production (research-use). Viral vectors were being studied extensively by research communities well before the COVID-19 pandemic. This is because of their proven efficiency and successful application in gene and cell therapies. With the COVID-19 outbreak, applications of viral vectors were repurposed to manufacture vaccines. Moreover, the technology and platform developers are making significant attempts to simplify the production pro...

  Large Molecule Bioanalytical Technologies Industry Overview The global large molecule bioanalytical technologies market was valued at USD 5.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13.5% from 2021 to 2028. Along with the ongoing shift in R&D programs for large molecules, there is increasing diversity in the type of therapeutics modality being tested analytically. This ongoing trend toward greater diversity demands a wider set of expertise to assess the quality attributes of the final products, thereby driving the market for large molecule bioanalytical technologies. Furthermore, the COVID-19 pandemic has created lucrative opportunities for key stakeholders of the market for large molecule bioanalytical technologies. Several CMOs and bio-manufacturers have shifted their business focus to the production of therapeutics against SARS-CoV-2 infection. Thus, demand for bioanalytical testing tools has grown significantly. Several initi...

  Spectrometry Industry Overview The global spectrometry market size was estimated at USD 14.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2021 to 2028. The development of technologically advanced spectroscopy instruments and consumables is anticipated to provide growth avenues to this market. Continuous evolution in spectrometry techniques has enhanced the use of spectrometers in the market. Key players are developing products that are easy to use and provide better outcomes which would help researchers to provide better results. This in turn is anticipated to aid growth over the forecast period. Gather more insights about the market drivers, restraints and growth of the Global Spectrometry market Spectrometry technology has emerged as one of the key technologies used in various analytical applications such as drug development procedures, proteomics, metabolomics, forensic analysis, and pharmaceutical analysis. The adoption of ...

  Gene Delivery Technologies Industry Overview The global gene delivery technologies market size was estimated at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028. The advent of cell and gene therapies has not only transformed the treatment of genetic and intractable diseases but has also played a major role in reshaping the entire pharmaceutical ecosystem. By end of 2019, over 27 cell and gene therapies were launched worldwide and nearly 990 companies are engaged in R&D and commercialization of advanced therapies. The constantly evolving landscape of advanced therapies is one of the key driving forces of the market for gene delivery technologies. Owing to the technological advancements with respect to nanotechnology and physical technology, advanced physical gene delivery methods such as magnetoporation, optoporation, sonoporation, and electroporation have been extensively studied. These techniques are gaini...

  Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Overview The global veterinary active pharmaceutical ingredients manufacturing market size was valued at USD 6.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028. The market is primarily driven by the increasing pet expenditures and number of veterinarians & veterinary visits and high prevalence of zoonotic diseases. The growing livestock population is also driving the market. According to the U.S. Department of Agriculture, there were 103.0 million cattle and 32.1 million beef cows in the U.S. in July 2020, and this number is expected to grow substantially in the coming years. Moreover, factors such as rise in R&D investments, advancements in procedures, high pet adoption rates, increased consumption of meat, and mandatory vaccination are anticipated to boost the market growth during the forecast period. The increasing number of oral formulations...

  Continuous Manufacturing Market In Pharmaceuticals & Biopharmaceuticals Overview The global continuous manufacturing market in pharmaceuticals and biopharmaceuticals size was valued at USD 919.7 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 13.85% from 2021 to 2027. In recent years, continuous manufacturing has gained traction as a viable solution within the pharmaceutical industry. This is primarily to minimize the pressure pertaining to reduce drug development time and costs while maintaining the supply and quality of the final product. As a result, the continuous manufacturing market is anticipated to witness healthy growth in the coming years. Continuous manufacturing enables the therapeutics developers to keep pace with the changing market demands. It allows a seamless drug production process from raw materials to the final product. Moreover, the risk of human error is reduced because it entails a smaller number of human resources ...

  DNA & RNA Banking Services Industry Overview The global DNA and RNA banking services market size was valued at USD 6.09 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.46% from 2021 to 2027. Biobanking approaches have been identified as key areas in accelerating the discovery and development of new therapeutic interventions, especially in oncology. This multidisciplinary approach is applied in all aspects of disease prediction, prevention, therapy monitoring, drug discoveries, and optimization. Therefore, a rise in cancer cases globally is expected to drive the demand for DNA and RNA banking services for cancer research. Cancer is the second most common cause of death in the U.S. after heart disease. According to the American Cancer Society estimates, more than 1.8 million new cancer cases were identified by the end of 2020 in the U.S. In addition, approximately 606,520 Americans were estimated to die in 2020 due to cancer. This high pr...